Alvotech Reports 420% Revenue Growth in 2024, Guides 20% Growth in 2025 Amid Regulatory Challenges

Alvotech reported a 420% revenue growth in 2024 and guides approximately 20% growth for 2025, with a revised full-year revenue outlook of $570 million to $600 million. Q3 licensing revenues were $81 million, supporting a 69% gross margin. The company holds a strong market position in the US and EU, but faces challenges with FDA compliance and a temporary loss in product revenues.